Studies from AstraZeneca Update Current Data on COVID-19 (Azd3152 Neutralizes Sars-cov-2 Historical and Contemporary Variants and Is Protective In Hamsters and Well Tolerated In Adults)

MLA

“Studies from AstraZeneca Update Current Data on COVID-19 (Azd3152 Neutralizes Sars-Cov-2 Historical and Contemporary Variants and Is Protective In Hamsters and Well Tolerated In Adults).” Pharma Business Week, 22 July 2024, p. 427. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.802089928&authtype=sso&custid=ns315887.

APA

Studies from AstraZeneca Update Current Data on COVID-19 (Azd3152 Neutralizes Sars-cov-2 Historical and Contemporary Variants and Is Protective In Hamsters and Well Tolerated In Adults). (2024, July 22). Pharma Business Week, 427.

Chicago

Pharma Business Week. 2024. “Studies from AstraZeneca Update Current Data on COVID-19 (Azd3152 Neutralizes Sars-Cov-2 Historical and Contemporary Variants and Is Protective In Hamsters and Well Tolerated In Adults),” July 22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.802089928&authtype=sso&custid=ns315887.